Ray Dalio Bridgewater Associates
Ray Dalio is the founder of Bridgewater Associates, one of the world’s largest hedge funds, known for its unique “principles-based” culture and systematic investment approach. Dalio’s investment philosophy emphasizes diversified portfolios, risk parity, and the importance of understanding economic cycles in shaping investment decisions. He has authored several books, including “Principles: Life & Work,” in which he details his management philosophies, personal experiences, and life lessons.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lam Research
LRCX
|
+$182M |
| 2 |
Qualcomm
QCOM
|
+$134M |
| 3 |
Apple
AAPL
|
+$126M |
| 4 |
Constellation Energy
CEG
|
+$114M |
| 5 |
Broadcom
AVGO
|
+$114M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$338M |
| 2 |
Johnson & Johnson
JNJ
|
+$276M |
| 3 |
Walmart Inc
WMT
|
+$270M |
| 4 |
Costco
COST
|
+$236M |
| 5 |
McDonald's
MCD
|
+$231M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Consumer Discretionary | 11.09% |
| 3 | Healthcare | 10.72% |
| 4 | Consumer Staples | 9.72% |
| 5 | Communication Services | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
651
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.6B
| $709K | ﹤0.01% |
8,826
| – | – |
|
652
Bright Horizons
BFAM
$3.86B
| $702K | ﹤0.01% |
+5,008
| New | +$648K |
|
653
Phreesia
PHR
$773M
| $694K | ﹤0.01% |
30,445
-31,869
| -51% | -$746K |
|
654
Boston Beer
SAM
$1.92B
| $692K | ﹤0.01% |
2,392
-442
| -16% | -$123K |
|
655
J&J Snack Foods
JJSF
$1.71B
| $689K | ﹤0.01% |
4,002
-622
| -13% | -$104K |
|
656
Ingles Markets
IMKTA
$1.67B
| $681K | ﹤0.01% |
9,127
-9,992
| -52% | -$735K |
|
657
Ventas
VTR
$47.9B
| $674K | ﹤0.01% |
10,517
-5,125
| -33% | -$299K |
|
658
BioNTech
BNTX
$23.5B
| $674K | ﹤0.01% |
+5,673
| New | +$522K |
|
659
Plexus
PLXS
$7.23B
| $664K | ﹤0.01% |
+4,856
| New | +$589K |
|
660
Integer Holdings
ITGR
$4.26B
| $661K | ﹤0.01% |
5,088
-11,208
| -69% | -$1.37M |
|
661
Halozyme
HALO
$12.2B
| $659K | ﹤0.01% |
11,515
-21,706
| -65% | -$1.24M |
|
662
Toro Company
TTC
$9.49B
| $646K | ﹤0.01% |
7,445
-1,074
| -13% | -$96.6K |
|
663
Hewlett Packard
HPE
$70.5B
| $645K | ﹤0.01% |
31,524
-35,680
| -53% | -$682K |
|
664
AMN Healthcare
AMN
$1.4B
| $638K | ﹤0.01% |
15,060
-62,723
| -81% | -$3.29M |
|
665
ICU Medical
ICUI
$4.61B
| $631K | ﹤0.01% |
3,464
-324
| -9% | -$48K |
|
666
Haemonetics
HAE
$4B
| $629K | ﹤0.01% |
7,826
-35,747
| -82% | -$2.89M |
|
667
National Healthcare
NHC
$3.38B
| $620K | ﹤0.01% |
4,928
-5,449
| -53% | -$685K |
|
668
NovoCure
NVCR
$1.91B
| $616K | ﹤0.01% |
39,383
-41,898
| -52% | -$760K |
|
669
Accenture
ACN
$108B
| $609K | ﹤0.01% |
1,723
-19,852
| -92% | -$6.53M |
|
670
Enviri
NVRI
$620M
| $607K | ﹤0.01% |
58,697
-82,021
| -58% | -$863K |
|
671
Canadian Imperial Bank of Commerce
CM
$108B
| $601K | ﹤0.01% |
+9,784
| New | +$530K |
|
672
Erie Indemnity
ERIE
$13.2B
| $595K | ﹤0.01% |
1,103
-1,686
| -60% | -$767K |
|
673
Enerpac Tool Group
EPAC
$1.93B
| $592K | ﹤0.01% |
+14,143
| New | +$567K |
|
674
Regeneron Pharmaceuticals
REGN
$80.8B
| $586K | ﹤0.01% |
557
-4,797
| -90% | -$5.34M |
|
675
Equitable Holdings
EQH
$14.1B
| $564K | ﹤0.01% |
+13,414
| New | +$550K |
|
Similar funds
Ray Dalio's Q3 2024 Portfolio in Review
As of Q3 2024, Ray Dalio held 956 positions worth $17.7B, down 7.8% from $19.2B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Ray Dalio withdrew a net $2.45B in Q3 2024, closing 183 positions and reducing 428 holdings. Its most notable exit was Walt Disney, an estimated $19.4M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Ray Dalio opened a new position in Micron Technology worth $102M.
- Ray Dalio's largest Q3 2024 buy was Micron Technology: 983,685 shares worth $102M.
- Ray Dalio added most to Lam Research in Q3 2024, an estimated $182M increase.
- Ray Dalio's biggest Q3 2024 reduction was Procter & Gamble, cutting an estimated $338M.
- Ray Dalio fully exited Walt Disney in Q3 2024, selling an estimated $19.4M.
- Ray Dalio's ten largest holdings make up 32% of its $17.7B portfolio in Q3 2024.
- Ray Dalio opened 79 new positions and closed 183 in Q3 2024.
- Ray Dalio's portfolio value fell 7.8% quarter-over-quarter to $17.7B.
Based on Bridgewater Associates's 13F filing for Q3 2024, filed 13 Nov 2024.